Malaria

Safety, Tolerability, Pharmacokinetics and Protective Efficacy of MAM01 in Healthy Adults

First-in-Human PfSPZ-LARC2 Vaccination/CHMI

Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)

L9LS in Women of Childbearing Potential in Mali

Induced Blood-Stage Malaria in Healthy Malaria-Naive Adults to Assess the Safety and Infectivity of Plasmodium Vivax Challenge Agent and Evaluate Transmission in Mosquito Feeding Assays

FocaL Mass Drug Administration for Vivax Malaria Elimination

Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge

Modifying Immunity in Children With DihydROartemisinin-Piperaquine (MIC-DroP)

Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants

Host and Parasite Factors That Influence Susceptibility to Malaria Infection and Disease During Pregnancy and Early Childhood in Ouelessebougou and Bamako, Mali

This is a Clinical Study to Assess Whether the Combination of SJ733 and Tafenoquine Will be a Safe and Rapidly Acting Anti-malarial for the Radical Cure of P. Vivax Malaria

Laboratory Evaluation of Pregnancy Malaria Vaccine Candidates/In-vitro Testing of Pregnancy Malaria Vaccine Candidates

Intermittent Preventive Treatment of Malaria in School-age Children to Decrease Community Transmission

Star Homes Project 2

Safety, Tolerability, Immunogenicity and Protective Efficacy of PfSPZ Vaccine and PfSPZ-CVac in Indonesian Adults Against Naturally-Transmitted Malaria

Safety and PK of MMV371 LAI in Healthy Adults and Adolescents in Rwanda

A Clinical Trial to Evaluate the Safety, Efficacy and Immune Responses After Vaccination With an Investigational RNA-based Vaccine Against Malaria

L9LS-R21 Interaction

Assessment of Safety and Immunogenicity of a Single Vial Presentation of R21/Matrix-M and Co-Administration With EPI Vaccines

Malaria Transmission in Humans and Mosquitoes at the Area of Sabou, Burkina Faso